Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - baloxavir marboxil - tablet, film coated - baloxavir marboxil 20mg

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - baloxavir marboxil - tablet, film coated - baloxavir marboxil 40mg

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - letermovir - film coated tablets - letermovir 240 mg - letermovir - prevymis is indicated for prophylaxis of cytomegalovirus (cmv) reactivation and disease in adult cmv-seropositive recipients [r+] of an allogeneic haematopoietic stem cell transplant (hsct).consideration should be given to official guidance on the appropriate use of antiviral agents.

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - letermovir - film coated tablets - letermovir 480 mg - letermovir - prevymis is indicated for prophylaxis of cytomegalovirus (cmv) reactivation and disease in adult cmv-seropositive recipients [r+] of an allogeneic haematopoietic stem cell transplant (hsct).consideration should be given to official guidance on the appropriate use of antiviral agents.

Canada - English - Health Canada

siga technologies, inc. - tecovirimat (tecovirimat monohydrate) - capsule - 200mg - tecovirimat (tecovirimat monohydrate) 200mg - miscellaneous antivirals

European Union - English - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirals for systemic use - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4.4 and 5.1).tecovirimat siga should be used in accordance with official recommendations.

Israel - English - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - film coated tablets - lenacapavir as sodium 300 mg - lenacapavir - sunlenca film-coated tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen, for oral loading prior to administration of long-acting lenacapavir injection.

Israel - English - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - solution for injection - lenacapavir as sodium 309 mg/ml - lenacapavir - sunlenca solution for injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

European Union - English - EMA (European Medicines Agency)

theratechnologies europe limited - ibalizumab - hiv infections - antivirals for systemic use - trogarzo, in combination with other antiretroviral(s), is indicated for the treatment of adults infected with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive antiviral regimen.

European Union - English - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infections - antivirals for systemic use - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4.2 and 5.1).sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4.2 and 5.1).